Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Bone Scan Index made easy, at last

Nature Reviews Urology volume 9, pages 245–246 (2012)Cite this article

Subjects

The Bone Scan Index (BSI) is a methodology used to quantify bone metastases and monitor changes under treatment. However, BSI is manually calculated and is, therefore, tedious and time-consuming to use, so it is not routinely implemented. A new automated platform to calculate BSI should help to increase its use.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. de Bono, J. S. et al. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet 376, 1147–1154 (2010).

    Article  CAS  Google Scholar 

  2. Tombal, B. & Lecouvet, F. Modern detection of prostate cancer's bone metastasis: is the bone scan era over? Adv. Urol. 2012, 893193 (2012).

    Article  Google Scholar 

  3. Clamp, A., Danson, S., Nguyen, H., Cole, D. & Clemons, M. Assessment of therapeutic response in patients with metastatic bone disease. Lancet Oncol. 5, 607–616 (2004).

    Article  Google Scholar 

  4. Venkitaraman, R. et al. Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer. J. Med. Imaging Radiat. Oncol. 53, 241–247 (2009).

    Article  CAS  Google Scholar 

  5. Messiou, C., Cook, G. & deSouza, N. M. Imaging metastatic bone disease from carcinoma of the prostate. Br. J. Cancer 101, 1225–1232 (2009).

    Article  CAS  Google Scholar 

  6. Therasse, P. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl Cancer Inst. 92, 205–216 (2000).

    Article  CAS  Google Scholar 

  7. Scher, H. I. et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J. Clin. Oncol. 26, 1148–1159 (2008).

    Article  Google Scholar 

  8. Imbriaco, M. et al. A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index. Clin. Cancer Res. 4, 1765–1772 (1998).

    CAS  PubMed  Google Scholar 

  9. Dennis, E. R. et al. Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. J. Clin. Oncol. 30, 519–524 (2012).

    Article  Google Scholar 

  10. Ulmert, D. et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2012.01.037.

Download references

Author information

Authors and Affiliations

  1. Service d'Urologie, Cliniques Universitaires Saint Luc, Avenue Hippocrates 10, B-1200, Brussels, Belgium

    Bertrand Tombal

Authors
  1. Bertrand Tombal
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tombal, B. Bone Scan Index made easy, at last. Nat Rev Urol 9, 245–246 (2012). https://doi.org/10.1038/nrurol.2012.79

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2012.79

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing